Growth Metrics

Insulet (PODD) Capital Expenditures (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -37.27%
Dec 31, 2025 428.57%
Sep 30, 2025 -13.95%
Jun 30, 2025 -134.96%
Mar 31, 2025 -77.05%
Dec 31, 2024 100.75%
Sep 30, 2024 18.67%
Jun 30, 2024 1.81%
Mar 31, 2024 158.47%
Dec 31, 2023 -288.06%
Sep 30, 2023 28.03%
Jun 30, 2023 49.52%
Mar 31, 2023 320.00%
Dec 31, 2022 -10.71%
Sep 30, 2022 -37.78%
Jun 30, 2022 45.16%
Mar 31, 2022 104.47%
Dec 31, 2021 -353.85%
Sep 30, 2021 -43.94%
Jun 30, 2021 1,087.80%
Mar 31, 2021 110.07%
Dec 31, 2020 -253.58%
Sep 30, 2020 -38.80%
Jun 30, 2020 415.48%
Mar 31, 2020 -94.53%
Dec 31, 2019 2,031.94%
Sep 30, 2019 174.23%
Jun 30, 2019 -176.38%
Mar 31, 2019 1,743.25%
Dec 31, 2018 100.89%
Sep 30, 2018 -209.67%
Jun 30, 2018 301.31%
Mar 31, 2018 -32.66%
Dec 31, 2017 197.16%
Sep 30, 2017 -34.69%
Jun 30, 2017 -47.86%
Mar 31, 2017 782.44%
Dec 31, 2016 -78.12%
Sep 30, 2016 384.52%
Jun 30, 2016 -13.13%
Mar 31, 2016 -9.25%
Dec 31, 2015 37.90%
Sep 30, 2015 890.20%
Jun 30, 2015 -94.13%
Mar 31, 2015 65.06%
Dec 31, 2014 -15.28%
Sep 30, 2014 -13.38%
Jun 30, 2014 66.34%
Mar 31, 2014 -22.69%
Dec 31, 2013 53.13%
Sep 30, 2013 12.05%
Jun 30, 2013 52.10%
Mar 31, 2013 -47.98%
Dec 31, 2012 -56.16%
Sep 30, 2012 83.80%
Jun 30, 2012 50.09%
Mar 31, 2012 -25.35%
Dec 31, 2011 -30.57%
Sep 30, 2011 23.09%
Jun 30, 2011 -8.08%
Mar 31, 2011 -0.69%
Dec 31, 2010 77.22%